A study to assess the safety, tolerability and pharmacokinetics of AZD4041 in Healthy Volunteers

Trial Identifier: D7460C00001
Sponsor: AstraZeneca
Collaborator:
National Institutes of Health (NIH)
Eolas Therapeutics INC.
NCTID:: NCT04076540
Start Date: October 2019
Primary Completion Date: November 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
United States of America, NV Las Vegas, NV, United States of America, 89113
United States of America, TX Austin, TX, United States of America, 78744